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Abstract
Purpose Glioma patients and their informal caregivers face
many challenges in living with the disease and its disease-
specific consequences. To better meet their needs, a system
to monitor symptoms, distress, and quality of life could prove
useful. We explored glioma patients’ and caregivers’ attitudes
and preferences toward monitoring in general and specifically
toward paper-and-pencil and computerized (eHealth) options.
Methods In total, 15 patients and 15 informal caregivers par-
ticipated in individual, semi-structured interviews. Interviews
were transcribed smooth verbatim and coded by two re-
searchers independently.
Results Advantages of monitoring generated by participants
include increased awareness of problems and their flow over
time, and facilitating supportive care provision. Disadvantages
include investment of time andmastering the discipline to mon-
itor frequently. Patients reported more disadvantages of moni-
toring, including practical and disease-specific impediments,
while caregivers mentioned more advantages. Preferences for
specific methods mentioned to monitor are highly personal but
most prefer to have an option for face-to-face contact to discuss
results of monitoring with health care professionals even in
computerized instruments.
Conclusions Informal caregivers view a monitoring system
more favorably than glioma patients. In developing an effi-
cient monitoring system to help glioma patients and caregivers
find their way to supportive care, a computerized instrument
with the added opportunity to contact a health care profession-
al seems to be the best option to advise.
Keywords Glioma . Brain tumor . Informal caregivers .
Supportive care needs . Preferences . eHealth
Background
Gliomas, the most common primary malignant brain tumors,
can have a devastating impact on the lives of both patients and
those close to them. These tumors lead to neurological symp-
toms that can cause a disease burden distinctly different from
other cancer patients [1]. For example, paresis, visual- per-
ceptual deficits, sensory loss, cognitive deficits, and seizures
are common [2], and changes in personality and behavior can
occur [3, 4].
As the disease progresses, symptoms may become more
pronounced and patients have to rely more on their informal
caregivers. Consequently, many informal caregivers experi-
ence considerable caregiver burden [5, 6], and psychological
distress is reported in approximately half of all family care-
givers [7]. Various studies have explored the needs of both
patients and informal caregivers related to information disclo-
sure and communication, service provision, and supportive
care options [8]. Meeting the needs of patients and informal
caregivers may reduce their symptoms and psychological
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distress and improve their quality of life (QOL). Patient- re-
ported outcome measures (PROMs) might help identify
symptoms and distress, track changes over time, and could
serve as an indicator of relevant topics to discuss [9].
Particularly, monitoring over time in combination with feed-
back is suggested to provide better insight into problems that
patients and caregivers encounter, and to facilitate referral to
appropriate supportive care options [10].
Few studies have focused on using monitoring instruments
in brain tumor patients [11–16]. Monitoring for QOL issues
[11], disease-specific issues [16], and distress and depression
[14] was found feasible in neuro-oncology patients in clinical
practice. However, none of these studies has included informal
caregivers reporting on their own problems. Moreover, in only
two studies [14, 16], the focus was on instruments reporting
results to patients themselves instead of to physicians.
Monitoring can be conducted in several ways: by means of
paper-and-pencil instruments and by means of computerized
or Web-based (eHealth) applications. It is expected that
eHealth applications could prove to be useful tools in
implementing monitoring in the health care system, because
of 24/7 availability, and report in real-time instead of retro-
spectively [17]. In introducing such innovations into clinical
practice, it is important to actively engage the end users (i.e.,
patients and caregivers) in order to improve the effectiveness
and uptake [18, 19].
Therefore, the present study aimed at examining the per-
spective of glioma patients and informal caregivers on moni-
toring their own symptoms, distress, and QOL. Our research
objectives were to discover (1) if glioma patients and informal
caregivers are interested in monitoring their own symptoms,
psychological distress, and QOL in clinical practice; and (2)
what the attitudes and preferences of glioma patients and in-
formal caregivers are toward paper-and-pencil instruments
and eHealth applications, and toward face-to-face and auto-
mated feedback. Based on study results, suggestions for an
efficient way to provide glioma patients and caregivers with
the means of reporting their concerns and obtaining appropri-
ate supportive care (e.g., symptommanagement interventions,
physical therapy or psychological support, or more informal
supportive care such as peer support groups) are provided.
Methods
Sample and procedure
Adult glioma patients and informal caregivers of glioma pa-
tients were recruited at the outpatient department of the VU
University Medical Center in Amsterdam. Patients were eligi-
ble if they (1) were >18 years of age and (2) were diagnosed
with a histologically confirmed WHO grade II, III, or IV gli-
oma. Caregivers were eligible if they (1) were >18 years of
age and (2) were the primary informal caregiver of a patient
with histologically confirmed WHO II, III, or IV glioma.
Neither patients nor caregivers could participate if they did
not speak Dutch. We employed purposive sampling to obtain
a varied sample with regard to diagnoses and disease stages.
The nurse practitioner or treating physician introduced po-
tential participants to the study by handing out an information
letter. With permission from the potential participants, a mem-
ber of the research team (FWBorKH) contacted them to ask if
they were willing to participate. The semi-structured inter-
views, taking approximately 60 min, were scheduled either
at the hospital or at a location of the participant’s preference.
All participants were interviewed individually. Interviews
were performed until data saturation was obtained in the pa-
tient and caregiver interviews separately, meaning that the last
interview(s) generated no new information [20]. All inter-
views were audiotaped. Information on disease and treatment
was extracted from the medical records. All participants
signed written, informed consent forms and the study was
approved after expedited review by the Institutional Review
Board of the VUUniversity Medical Center (protocol number
13/309).
Interviews
All interviews (N = 30) were performed by one member of the
research team (KH). A semi-structured interview schedule
was used (see Table 1). Interview topics and questions were
based on our clinical experience and literature [21–23]. If
open-ended questions elicited little response, prompts were
offered.
We proposed three methods of monitoring (see the Online
Resource for additional information). Participants were pre-
sented with a paper-and-pencil screening instrument (the
Patient Concerns Inventory [16] (PCI) for patients; the
Distress Thermometer [24] (DT) for informal caregivers).
Additionally, it was explained that this can be combined with
face-to-face feedback and referral if needed. Furthermore, a
computer-based monitoring application was presented:
Oncoquest [25], a touch screen application available in the
outpatient clinic, which can be paired with face-to-face feed-
back and referral. Finally, an eHealth application was intro-
duced bymeans of screenshots: Oncokompas [26], an eHealth
instrument available from home, which provides instant tai-
lored feedback and referral to personalized supportive care
options. Both Oncoquest and Oncokompas comprise QOL
measurements. These different instruments were selected be-
cause they vary in the degree to which technology is involved.
Data analysis and reporting
The interviews were transcribed smooth verbatim using F4
software [27]. Data analysis was conducted by two coders
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(WC and FWB) by thematic analysis [28, 29]. Both coders
read the transcripts several times to familiarize themselves
with the content and highlighted sections of the transcripts
that were related to the research objectives and independently
selected and coded these into key issues and themes (separate-
ly for the patient and caregiver interviews). After every three
interviews, the coders discussed their findings, refined the key
issues and themes, and resolved possible differences until con-
sensus was reached guided by a third researcher (CvU).
Finally, one coder (FWB) examined the raw transcripts again
to ensure that the analytical process was robust and to confirm
that all data were reflected in the coding. In this paper, the
consolidated criteria for reporting qualitative research
(COREQ) [30] were followed. All quotes provided were




In total, 18 patients received the study information and all
were willing to participate (see Fig. 1 for participant
flow). Two patients did not show on the scheduled meet-
ing time, and one interview was canceled because data
saturation had already occurred. Twenty-four informal
caregivers were approached with study information. Six
informal caregivers declined to participate: Three care-
givers were too busy, two caregivers were too
overwhelmed, and one caregiver was gravely ill. In three
additional cases, a suitable date for the interview could
not be scheduled. Data saturation started after approxi-
mately 12 interviews in both patient and caregiver sam-
ples, after which an additional three interviews were con-
ducted to ensure that we had indeed reached data satura-
tion. In total, a representative sample of 15 glioma pa-
tients and 15 informal caregivers with a wide range of
pathologic diagnoses in different disease stages were
interviewed (see Table 2 for details). Below, the results
that were relevant in terms of the research objectives are
described.
Monitoring symptoms, distress, and QOL in clinical
practice
Current supportive care provision
Most patients mentioned to be content with the informa-
tion provided by the hospital, while many informal care-
givers felt this did not suffice or was unclear. Patients
indicated that because of time constraints and a varying
level of interest from physicians, they did not always
feel there was enough attention for the person behind
the disease:
Table 1 Interview topics
Topics Key questions
1. Unmet supportive care needs Current supportive care provision
What is your experience with referral to supportive care and use
of supportive care options?
2. Willingness to monitor
symptoms or problems and
referral to supportive
care in clinical practice
Monitoring needs and problems
What are your thoughts about monitoring? Could you name
advantages and disadvantages?
How would monitoring be of most use to you; for which symptoms
or problems?
Personalized feedback
How would you feel about receiving personalized feedback based
on the symptoms and problems you have monitored?
Referral to supportive care
How would you feel about receiving referral to supportive care
options based on the symptoms and problems you have monitored?
What are your thoughts on a system of monitoring, feedback and
referral to improve supportive care provision?
3. Attitudes and preferences
towards instruments as a
means to monitor symptoms,
distress and QOL
Paper-and-pencil instrument (PCI or DT)
What are your thoughts on this paper-and-pencil instrument?
Computerized and eHealth application (Oncoquest and Oncokompas)
What are your thoughts on these computerized applications?
Which of these three instruments would you prefer, and why?
PCI Patient Concerns Inventory, DT Distress Thermometer, QOL quality of life
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‘Yes, it just doesn’t feel so… easy and… familiar, so to
speak, and you have the feeling that it all has to be done
in a hurry, so, I think, yes... never mind.’ (Female glio-
blastoma patient (42 years), currently under treatment)
With regard to referral to supportive care, patients indicated
that although their symptoms were heard, supportive care was
often only offered if actively requested. At the same time, both
patients and caregivers stated that they were uncertain who
their treating physician is. Moreover, informal caregivers
mentioned to find it difficult to ask for help for themselves,
as they feel the patient should be the center of attention.
Patients said to receive several forms of supportive care,
e.g., a psychologist, rehabilitation, advance care planning,
and spiritual care, while caregivers mostly said to rely on
support from those close to them.
Advantages and disadvantages of monitoring
Table 3 lists the advantages and disadvantages of monitoring.
An important advantage of monitoring indicated by both pa-
tients and caregivers is that it can help you learn more about
yourself and that it can create more attention for symptoms or
issues and their flow over time. Monitoring was mentioned to
facilitate the conversation with the treating physician and,
therefore, to be useful in preventing the problems from
worsening:
‘That you… that you had better follow things over time,
what is happening to you, how you are doing, yes. Well
you know, whether your condition has indeed improved
or deteriorated, or your weight... or, those kinds of
things. That you are triggered to… to take the necessary
action if things are not well.’ (Male grade III
oligodendroglioma patient (65 years), progressive dis-
ease suspected)
Downsides of monitoring were also mentioned. Both pa-
tients and caregivers said that it could be difficult to master the
discipline to monitor regularly and that it can be time consum-
ing. Furthermore, they feared that it would increase awareness
of problems they did not know they had and that it could be
difficult to face (worsening) symptoms:
‘But I also have to be careful that I do not go and sit
there thinking up things, like, what do I find so hard..’
(Male caregiver (76) of a grade III astrocytoma patient
with stable disease)
Participants who experienced no needs considered monitor-
ing to be pointless. However, patients and caregivers did feel
that it might be useful for others who do experience needs and
are less able to cope with symptoms or distress.
Preferences regarding monitoring
Patients generated mainly physical symptoms as topics to
monitor. Cognitive deficits, changes in personality, mood,
and emotional reactions were also mentioned. Caregivers
mainly mentioned mental symptoms, such as depressive
mood and stress. Moreover, changes in the relationship with
the patient and in everyday life, and coping with the patient’s
symptoms were frequently mentioned. Many topics men-
tioned by caregivers were associated with grief and
acceptance:
‘Also the… amount of time I really spend with my
husband, quality time. I have been wondering about…
those are also things I wonder about. Like, is this nor-
mal what is happening here. What… what do people do
when you tell them you only have so and so long to live.’
(Female caregiver (52 years) of a glioblastoma patient
with disease progression)
Both patients and caregivers thought receiving feedback on
the results of monitoring was essential. They indicated that
with feedback, changes over time become apparent, and it
can provide more insight into the problems experienced.
Patients would like to know if symptoms are normal,
18 patients 





18 patients were 
willing to participate 
18 caregivers were 
willing to participate 
15 patients were 
interviewed 
15 caregivers were 
interviewed 
6 caregivers declined: 
- 3 too busy 
- 2 overwhelmed 
- 1 became ill 
In 3 cases, a suitable 
date for the interview 
could not be 
scheduled. 
3 patients were not 
interviewed: 
- 2 did not show 
- 1 interview was 
cancelled due to data 
saturation 
Fig. 1 Flowchart of participant
inclusion
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considering the circumstances. Several caregivers mentioned
that feedback and advice alone could provide solace:
‘Yes, in itself I do believe that it... may give some relief
since you know there is care available. Oh dear, not that
you, that I would immediately use it, but I, again believe,
the idea that you, the sheer knowing that it is there... that
could be very comforting.’ (Female caregiver (52 years)
of a glioblastoma patient who is under treatment)
Subsequent referral to supportive care was considered use-
ful by most patients and caregivers. Informal caregivers
believed that referral after monitoring can save time and effort
to seek out help.
Different monitoring instruments
Tables 4, 5 and 6 provide an overview of participants’
thoughts on the different monitoring instruments.
Generally, patients felt that any of the presented instru-
ments would be an improvement in existing health care,
as it can help guide the discussion with the physician.
Some even see its implementation as a form of good
Bcustomer service.^ Patients had various different
Table 2 Demographic characteristics of the participants
Participant Age Gender Relationship to
the patient
Diagnosis of the patient Time since diagnosis Disease status
Patient 1 58 Male N/a Glioblastoma 3 months Under treatment
Patient 2 51 Male N/a Glioblastoma 1 year and 3 months Under treatment
Patient 3 50 Male N/a Grade III astrocytoma 3 years Stable
Patient 4 28 Female N/a Grade II astrocytoma 6 years Stable
Patient 5 50 Male N/a Grade II oligodendroglioma 8 years Stable
Patient 6 65 Male N/a Grade III oligodendroglioma 2 years Progressive disease
suspected
Patient 7 73 Female N/a Grade II astrocytoma, then
glioblastoma
2 years; 7 months Under treatment
Patient 8 42 Female N/a Glioblastoma 6 months Under treatment
Patient 9 66 Female N/a Glioblastoma 1 year and 3 months Stable disease
Patient 10 50 Male N/a Grade III oligodendroglioma 4 years Stable disease
Patient 11 53 Female N/a Grade III oligodendroglioma 1 year and 6 months Stable disease
Patient 12 51 Male N/a Grade II oligodendroglioma 8 years Stable disease
Patient 13 43 Male N/a Grade II astrocytoma 1 year and 7 months Stable disease
Patient 14 43 Male N/a Grade II oligo-astrocytoma 2 years and 5 months Stable disease
Patient 15 40 Male N/a Grade II astrocytoma 2 years and 6 months Stable disease
Caregiver 1 52 Female Spouse Glioblastoma 11 months Under treatment
Caregiver 2 55 Female Spouse Grade II oligodendroglioma, then
grade III oligodendroglioma
11 years, 7 years Stable disease




58 Male Spouse Grade III oligodendroglioma 1 year and 6 months Stable disease
Caregiver 5 53 Female Spouse Grade III oligo-astrocytoma 7 months Stable disease
Caregiver 6 58 Female Spouse Glioblastoma 6 months Disease progression
Caregiver 7, partner
of patient 5
52 Female Spouse Grade II oligodendroglioma 8 years Stable
Caregiver 8 45 Female Spouse Glioblastoma 4 months Disease progression,
under treatment
Caregiver 9 40 Female Spouse Glioblastoma 2 years and 7 months Under treatment
Caregiver 10, partner
of patient 15
38 Female Spouse Grade II astrocytoma 2 years and 6 months Stable disease
Caregiver 11 67 Female Spouse Glioblastoma 4 years and 8 months Stable disease
Caregiver 12 58 Female Spouse Grade II oligodendroglioma 6 years Stable disease
Caregiver 13 76 Male Spouse Grade III astrocytoma 6 years Stable disease
Caregiver 14 53 Female Spouse Grade III oligodendroglioma 2 years and 2 months Stable disease
Caregiver 15 43 Female Spouse Grade II oligodendroglioma 6 years Stable disease
N/a not applicable
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opinions on social influence by peers or health care pro-
fessionals. A few caregivers indicated that recommenda-
tion by the treatment team specifically would encourage
them to use a monitoring instrument:
‘I take that seriously, yes. Yes, of course. That… you
must take it seriously. I do. Of course, it is not something
you can simply wave away. I see it as an exam. No, then,
yes then I will.’ (Female caregiver (67 years) of a glio-
blastoma patient with stable disease)
Paper-and-pencil instrument
Patients said the PCI seems to be a simple instrument that
would be easy to complete because the different topics are
concrete and clear, and believe that it can help recognize
problems and initiate discussion (Table 4). As the PCI
does not allow for an indication of the severity of symp-
toms, patients said it only provided a snapshot picture of
their concerns, which may hinder its usefulness. Patients
indicated that they expected the social cues from face-to-





Motives pro use Would be useful to learn more about yourself, to gain insight Patients and caregivers
Could create more attention for symptoms and concerns Patients and caregivers
Could facilitate initiation of professional supportive care Patients and caregivers
A structured approach helps to identify topics to discuss Patients
Could help with rehabilitation (e.g. useful for improving
physical fitness)
Patients
Could help you recognize recurring issues Caregivers
Would be useful to obtain a clear view of flow of issues Caregivers
Would be useful to compare one’s own issues with others in
a similar situation
Caregivers
Would be useful when paired with immediate feedback Caregivers
Could be useful to prevent worsening of symptoms and
concerns
Caregivers
Could help with process of grief Caregivers
Would be useful to learn how to deal with the situation Caregivers
Motives con use Difficult to master the discipline Patients and caregivers
Could make you more aware of symptoms and concerns
you did not know you had
Patients and caregivers
It is time-consuming; yet another chore to complete Patients and caregivers
Would not be useful when there are no symptoms or
concerns
Patients and caregivers
Reluctance to share details on everyday functioning with
treatment team
Patients
It is unclear who to contact about the different symptoms
and problems
Patients
Would be disappointing to see symptoms worsen Patients
Language problems could make monitoring difficult Patients
Would not be able to monitor without help from partner Patients
Could make you feel like a patient yourself Caregivers
Could be difficult to face issues Caregivers
Would not be useful when you are already highly aware




To learn more about yourself Patients
Could be useful for others who are less able to cope Caregivers
Knowledge that results from monitoring can help others
in the future
Caregivers
Could be useful for research/hospital purposes Patients and caregivers
Could put the symptoms into perspective Patients
Could be useful when contact with treatment team is not
sufficient
Patients
Could be useful as a legacy for children Patients
QOL quality of life
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face feedback would help them in the interpretation of
the advice provided and would allow them to ask
questions.
Informal caregivers felt the DT included relevant topics
and could help initiate a conversation about supportive
care (Table 4). They expected the DT to be easy to com-
plete. Face-to-face feedback was mentioned to be highly
appreciated and could make them feel acknowledged.
However, restrictions of the DT mentioned include that
some caregivers found it too superficial and that the an-
swer options do not do justice to subtle fluctuations in
symptoms or concerns. They indicated that questions
were difficult to interpret and that it would be difficult
to monitor supportive care needs over time.
Computerized application: Oncoquest
Patients indicated that Oncoquest provides a more detailed
description of needs compared to the PCI (Table 5). The op-
tion to receive face-to-face feedback was mentioned to be an
advantage, although some patients indicated that they would
also like to receive feedback in written form:
‘Preferably on paper, but I also say that because of my
current… short-term memory.’ (Male grade III
oligodendroglioma patient (65 years), progressive dis-
ease suspected)
Participants mentioned certain restrictions of Oncoquest,
e.g., difficulty of answering multiple-choice questions.
Oncoquest’s availability at the outpatient clinic only (and not
in the home-situation) could limit the frequency of monitor-
ing, and the timing could be poor as, during a hospital visit,
they might receive bad news. Other downsides mentioned
were investment of time, money (parking costs), increased
fatigue as a result of completing a series of questions, and
privacy concerns, as it may be unclear to patients what hap-
pens with their data.
Caregivers mentioned more advantages of Oncoquest
(Table 5). They indicated to expect that completing
Oncoquest would not take long, and the answers go straight
to the physician. The availability of the instrument at the out-
patient clinic was seen as an advantage by some, as at this
time, their focus is already on the disease. Others indicated
that completing the questions from home would be better:
Table 4 Perceived use of paper-and-pencil instruments
Key issues Themes





PCI is an expected improvement
in health care
Topics raised by the PCI can help recognize problems and
initiate discussion
Patients
Topics raised by the PCI are concrete and clear Patients
The PCI is simple and easy to complete Patients
Indication of the severity of symptoms can follow in
conversation
Patients
Implementing PCI would be good ‘customer service’ Patients
PCI would be preferred in case of visual problems
(paper-and-pencil is easier than computer)
Patients
With the PCI, monitoring
symptoms over time seems
difficult
PCI provides a Bsnapshot picture^ Patients
PCI would be paired with
face-to-face feedback
Social cues help in interpretation of feedback/advice Patients
Allows you to ask questions Patients
Personal contact Patients




The DT is an expected
improvement in health care
The DT can help initiate a conversation about supportive care Caregivers
DT is easy to complete Caregivers
Topics raised by the DT are relevant to the caregiving situation Caregivers
Topics raised by the DT can help reflect on own situation Caregivers
The DT seems to have certain
restrictions
The DT is too brief Caregivers
Answer options do not do justice to subtle fluctuations Caregivers
Difficult to monitor symptoms and concerns over time Caregivers
Questions are difficult to interpret Caregivers
Name of instrument is too negative Caregivers
The DTwould be paired with
face-to-face feedback
Receiving personal attention from health care
professional makes you feel acknowledged
Caregivers
PCI Patient Concerns Inventory, DT Distress Thermometer
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‘Well, my first thought is not… not like, then and
there. Since, as I have already said, the moments that
we go to the hospital are always a little tense... and
I… I am more focused on my husband.’ (Female
caregiver (52 years) of a glioblastoma patient with
disease progression)
Face-to-face feedback was again highly appreciated for
similar reasons as mentioned by patients.
eHealth application: Oncokompas
Patients expected Oncokompas to empower the user, increas-
ing knowledge of symptoms or concerns while allowing you
to take control of your own needs (Table 6). Caregivers ex-
pected Oncokompas to reduce the barrier for exploring
supportive care options for themselves. Other advan-
tages mentioned included the instant, tailored advice
which could facilitate finding supportive care options,
Table 5 Perceived use of a computerized monitoring instrument
Key issues Themes




Oncoquest is an expected
improvement in health
care
Oncoquest can help guide the conversation with the physician Patients and caregivers
Improves relationship with the physician Caregivers
Provides a more detailed description of symptoms and concerns
than PCI
Patients
Completing Oncoquest does not take long, answers go straight
to doctor
Caregivers
Oncoquest seems to have
certain restrictions
Questions are difficult to answer, too many options Patients
Answer options (multiple choice) appeal more than with DT,
but are still too superficial
Caregivers
Takes time to answer the questions in a meaningful way Caregivers
Investment of time leads to fatigue, and loss of overview Patients
With a touch screen application, there are privacy concerns Patients
The touch screen application is seen as a ‘cool gadget’, but not
beneficial for self
Caregivers
Use of a computer could be difficult for certain individuals
(elderly; people with low literacy)
Patients
Perceived (dis)advantages
of the availability at
outpatient clinic
Availability in clinic is convenient, as you are already focused
on the disease
Caregivers
Elderly people or people who are not used to working with the
computer, can ask for help in the outpatient clinic
Caregivers
Timing of completing Oncoquest is bad in combination with
getting test results
Patients and caregivers
Availability in clinic is not convenient, hospital visit is already
stressful
Caregivers
Availability in clinic is not convenient, would be more practical
from home
Caregivers
Availability in clinic is not convenient, the patient could be
looking over your shoulder
Caregivers
Frequency of monitoring is restricted by availability at
outpatient clinic
Patients
Would cost time in outpatient clinic Patients
Would cost money (parking costs) Patients
Oncoquest would be paired
with face-to-face feedback
Personal contact is an advantage Patients
Allows you to ask questions Patients
Social cues help in interpretation of feedback/advice Patients
Receiving feedback quickly is important Caregivers
Prefer to receive advice/feedback in written form as well Patients
Receiving personal attention from health care professional
makes caregiver feel acknowledged
Caregivers
Face-to-face feedback would not be a prerequisite (e.g., if filed
in medical record, or if there is an option to contact a
professional)
Patients
The combination of eHealth and face-to-face feedback is good Caregivers
PCI Patient Concerns Inventory, DT Distress Thermometer
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and the trustworthiness of the information provided as it
comes from the hospital. Patients and caregivers felt
using Oncokompas from their home computer would
be convenient, as it would allow them to monitor at a
time and frequency of their choosing:
‘I believe yes, that… that would, of course, be very
convenient if you could just arrange it through the
computer. […]. Then you don’t have to be there at half
past ten. […] So yes, that might be even more appealing.
Also because you then could do this more often. Without
constantly going to and fro.’ (Male grade II
oligodendroglioma patient (51 years), stable disease)
Furthermore, patients appreciated being able to take their
time to complete questions, as this can take longer in people
with language problems. Caregivers especially appreciated
the flexible timing, as during hospital visits the focus is usu-
ally on the patient and not on them. Patients did stress that
Oncokompas should not replace existing health care but rather
exist as a supplement.
Patients and caregivers also identified restrictions. With
Oncokompas, there is no face-to-face contact with health care
professionals, which was experienced as impersonal. Patients
furthermore indicated that their privacy should be assured
while using the website. They also identified practical diffi-
culties such as undertaking action independently following the
Table 6 Perceived use of an eHealth monitoring instrument
Key issues Themes
Perceived use of an eHealth
application: Oncokompas
Oncokompas is an expected
improvement in the existing
health care
Oncokompas would increase own knowledge of what
to do with symptoms
Patients
Oncokompas allows you to take control of your own
symptoms and concerns
Patients
Oncokompas would facilitate the search for
supportive care
Patients and caregivers
Oncokompas could provide tailored information on
the diagnosis and what to expect
Caregivers
Feedback and advice is instantly provided, much
faster than face-to-face feedback/advice
Patients and caregivers
Information is of good quality, comes from the
hospital itself
Patients and caregivers
Oncokompas has a clear design Caregivers
Oncokompas would be appreciated as addition to
existing health care
Patients
Using a computer system from
home would have advantages
It is convenient, allows you to monitor at a time of
your choosing, at home
Patients and caregivers
Easier to adjust the frequency of monitoring Patients
Low threshold for use Caregivers
Allows you time to think about the phrasing of
problems (in case of language problems)
Patients
Allows you to read the feedback/advice again later Patients
Preferred over face-to-face, because during hospital
visits the focus is on the patient
Caregivers
Oncokompas would have certain
restrictions in its usefulness
Lacks personal contact; digital feedback and advice
feels impersonal
Patients and caregivers
Can be difficult to take action following the feedback
and advice independently
Patients
Low expected use of Oncokompas, because it is
difficult to monitor your own symptoms
independently (discipline; severe fatigue)
Patients
Answer options in Oncokompas seem difficult to
compare with own situation
Patients
It would take a lot of time to complete the online
questionnaires
Patients and caregivers
Low expected use of Oncokompas, because it takes
a lot of time
Caregivers
Privacy has to be assured Patients
There should be room for remarks on the website Caregivers
A combination of face-to-face and digital is preferred Patients and caregivers
Oncokompas would not be
perceived as useful for self
Not useful for self now, but possibly useful at a later stage Patients
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advice. A number of patients indicated they are less able to use
computers than before, due to loss of strength in their hands,
memory problems causing issues with passwords, and fatigue,
language, or visual problems:
‘Yes, I am not someone who… who really likes to, as it
were, crawl behind my computer and then... that… that
actually takes quite a lot of effort nowadays.’ (Male
grade IV glioblastoma patient (51 years), currently un-
der treatment)
Both patients and caregivers expected completing the ques-
tionnaires online would take a lot of time. Caregivers explic-
itly mentioned that this would likely result in a low expected
use of Oncokompas.
Discussion
This study is the first to evaluate neuro-oncology patients’
and caregivers’ preferences and attitudes regarding a sys-
tem of monitoring symptoms, distress, and QOL, in order
to obtain insight into an efficient way to report symptoms
and concerns and to provide them with appropriate sup-
portive care options when needed. First, we evaluated
patients’ and caregivers’ issues with the current provision
of supportive care. Although in both groups many similar
issues were reported, especially caregivers report prob-
lems that remain untreated. Caregivers often find it diffi-
cult to ask for care for themselves, which is in line with
previous studies [4]. This stresses the need to make sup-
portive care options more readily available for caregivers
specifically.
To achieve this, a system based on monitoring symptoms,
distress, and QOL might be useful. Most glioma patients and
caregivers viewed this type of system favorably. Members of
our research group have previously investigated the needs of
breast cancer and head and neck cancer patients regarding on-
line monitoring [21]. Although many of the more general
(dis)advantages generated by those patients are similar, such
as enabling one to gain insight into changing symptoms, glioma
patients generated additional disease-specific or practical disad-
vantages. They appear more concerned with the ultimately pro-
gressive course of the disease, and cognitive problems that may
cause them to need help using this system. Similar difficulties
have been found in other eHealth initiatives for glioma patients
[31]. Because of these specific difficulties, implementing a
monitoring system may be less suitable in this patient popula-
tion. Indeed, glioma patients’ reactions to both computerized
monitoring instruments were mixed. A solution could be to
have the patient and caregiver complete the instruments’ ques-
tions together—although this would place additional burden on
caregivers and may raise privacy issues.
Caregivers generally viewed a monitoring system more
favorably than patients. They indicated that it may facilitate
the initiation of supportive care when needed, which could be
a consequence of their larger proportion of unrecognized and
untreated issues. Many patients and caregivers did stress that
feedback of the results and referral to supportive care should
be an integral part of using a monitoring system in clinical
practice, a notion that is supported by Mitchell [10].
When presented with an eHealth application that provides
instant tailored feedback and options for referral
(Oncokompas), many patients expected difficulty in taking
action independently upon receiving automated feedback.
Caregivers expected to benefit more from Oncokompas, as
this online system can decrease the barrier to contact health
care professionals for their own needs. A requirement men-
tioned by both patients and caregivers was that completing
online questions should not take too long, because of a de-
creased expectancy of use with an increased investment of
time. Moreover, both patients and caregivers appreciated ad-
ditional options for face-to-face feedback. This could be as
subtle as adding the option to contact a health care profession-
al in Oncokompas.
This study has some limitations. The study sample is rela-
tively small and comprises a mixed group of low- and high-
grade glioma patients and caregivers, possibly limiting the
generalizability of our findings. Because we employed a pur-
posive sampling method to ensure that we included partici-
pants with a wide range of neuro-oncological diagnoses in
different disease stages, any differences between low- and
high-grade populations might not show. In addition, there
are relatively few patient participants who had recently been
diagnosed, and the distribution inmale/female participants is a
slight exaggeration of the usual distribution seen in glioma
patient and caregiver populations (i.e., more male patients
and more female caregivers). Some patients displayed evident
issues with memory retrieval, difficulty finding words, and
diminished mental flexibility during the interviews. The ex-
amples of monitoring instruments were presented on paper
(e.g., screenshots), which may have made it difficult for some
participants to fully understand the functionalities of the in-
struments. In further development of eHealth monitoring in-
struments specifically, a usability test with the intended end
users is recommended [32].
To summarize, while the preferred method for monitor-
ing remains highly personal, with some preferring online
self-management options and others preferring only face-
to-face care, the desired way to proceed is likely to com-
bine online and face-to-face care: Bblended care.^
Developing a computerized form of monitoring with the
possibility to contact a health care professional if needed
seems to be advised. This, in itself, can raise questions
about feasibility and cost-effectiveness which should be
addressed in further studies.
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Regardless, three general conclusions can be drawn from
this study. First, a system of monitoring symptoms, psycho-
logical distress, and QOL appears to be viewed more favor-
ably by caregivers than by glioma patients. Second, glioma
patients experience disease-specific symptoms that may hin-
der them in using a monitoring instrument independently. And
finally, both patients and caregivers appear to prefer a com-
puterized form of monitoring as long as there is the option to
contact a health care professional if needed.
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